Professional 503-B Sterile Manufacturing Pharmacy Opportunity.
This state-of-the-art pharmaceutical manufacturing facility represents a turnkey investment opportunity in the specialized 503-B compounding sector. The facility features a comprehensive 14,500 square foot build-out with a 6,500 square foot cleanroom environment designed to meet stringent pharmaceutical manufacturing standards.
Facility Specifications:
- Total facility: 14,500 square feet
- Cleanroom space: 6,500 square feet
- FDA certification compliant
- Advanced pharmaceutical manufacturing technology
- Complete build-out ready for operations
Regulatory Compliance:
The facility maintains FDA certification standards required for 503-B outsourcing facilities, positioning it to serve hospitals, healthcare systems, and other institutional customers requiring sterile compounded medications.
Market Position:
The 503-B compounding pharmacy sector serves critical healthcare infrastructure needs, providing sterile preparations that are not commercially available. This facility is strategically positioned to address growing demand for specialized pharmaceutical compounding services in the Colorado market.
Investment Structure:
This represents a pre-operational investment opportunity requiring qualified buyers to establish operational protocols, staffing, and customer relationships. The substantial infrastructure investment has been completed, providing a foundation for pharmaceutical operations.
Due Diligence Requirements:
Prospective buyers must provide proof of funds and execute a non-disclosure agreement before accessing detailed facility specifications and financial projections.
Industry: Specialized Pharmaceutical Manufacturing
Facility Status: Complete build-out, pre-operational